Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018482

« Back to Dashboard
NDA 018482 describes PROCARDIA, which is a drug marketed by Pfizer and is included in two NDAs. It is available from three suppliers. Additional details are available on the PROCARDIA profile page.

The generic ingredient in PROCARDIA is nifedipine. There are thirty-nine drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the nifedipine profile page.

Summary for NDA: 018482

Therapeutic Class:Cardiovascular Agents

Pharmacology for NDA: 018482

Mechanism of ActionCalcium Channel Antagonists

Suppliers and Packaging for NDA: 018482

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CAPSULE;ORAL 018482 NDA Pfizer Laboratories Div Pfizer Inc 0069-2600 0069-2600-66 100 CAPSULE in 1 BOTTLE (0069-2600-66)
CAPSULE;ORAL 018482 NDA REMEDYREPACK INC. 52125-126 52125-126-02 30 CAPSULE in 1 BLISTER PACK (52125-126-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 24, 1986TE:RLD:No

Expired Orange Book Patents for NDA: 018482

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
CAPSULE;ORAL018482-001Approved Prior to Jan 1, 19823,644,627► subscribe
CAPSULE;ORAL018482-002Jul 24, 19863,644,627► subscribe
CAPSULE;ORAL018482-001Approved Prior to Jan 1, 19823,784,684► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.